Additionally, while a plateau in weight loss was observed in the placebo group at week 18, weight-loss with cagrilintide continued throughout the 26 weeks
About This Product Products specifications Bacteriostatic Water for Injection, USP is a sterile, nonpyrogenic preparation used for diluting or dissolving drugs intended for parenteral injection
A: Some people may experience joint pain, swelling in the arms or legs, or redness at the injection site
GIP Receptor Activation Pancreatic Effects: Enhanced insulin secretion (particularly postprandial), improved beta cell function Adipose Tissue: Promotes fat storage in subcutaneous (not visceral) depots, improves insulin sensitivity Lipid Metabolism: Reduces circulating triglycerides, improves HDL cholesterol CNS Effects: May enhance GLP-1 mediated appetite suppression GLP-1 Receptor Activation Appetite Regulation: Hypothalamic POMC neuron activation, reduced food intake Gastric Emptying: Delayed emptying prolongs satiety Hepatic Glucose Regulation: Reduces hepatic glucose production Beta Cell Protection: Anti-apoptotic effects, improved function Synergistic Advantages The combination of GIP and GLP-1 activation produces effects greater than either alone: GIP counteracts GLP-1-induced hepatic glucose regulation during hypoglycemia (safety benefit) GIP enhances insulin secretion while GLP-1 suppresses appetite (complementary actions) Combined effects on energy metabolism and fat distribution superior to GLP-1 alone [6] Research Applications Tirzepatide has been evaluated in over 15,000 participants across comprehensive clinical trial programs spanning diabetes, obesity, and metabolic dysfunction
8.3 Bo qun l dng da nhng ni kh ro, trnh nhng ni iu kin khc nghit nh d b tc ng bi nng ma
